project id: TCGA-KIRP; case submitter id: TCGA-DW-5561; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.52; rna integrity number: 9.2; spectrophotometer method: UV Spec; age at index: 51; days to birth: -18744; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1957; age at diagnosis: 18744; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage I; ajcc clinical t: T1a; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1a; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 414.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.9726027397260273; pack years smoked: 36.0; years smoked: 36.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.5; longest dimension: 0.6; oct embedded: No; shortest dimension: 0.2; portion submitter id: TCGA-DW-5561-01A-01; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 85.0;